Insider Cluster (2 insiders) ·Filed Jul 13, 2026

PTCT

PTC THERAPEUTICS, INC.
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $267K total
Actionable Insight • Neutral

Insider sales are trivial in size and consistent with routine option-exercise diversification. No bearish read-through. Monitor next quarterly earnings (likely late July/early August) for fundamental updates on PTCT's pipeline and commercial performance.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
PTCT ▼ -8.24% at T+20d
NEUTRAL call ✗ call lost -8.24% · α vs SPY -11.42% · entry $81.33 → $74.63
Next anchor: T+60d in 3d
Latest observation: T+56 -29.87% FF3 residual α
Entry anchored
Jul 10, 03:59 PM ET
via exchange tick
T+1d
-4.02%
call -4.02% · α -4.38%
$78.06
settled 3mo ago
T+5d
-3.37%
call -3.37% · α -2.58%
$78.59
settled 3mo ago
T+20d
-8.24%
call -8.24% · α -11.42%
$74.63
settled 8w ago
T+60d
—
call — · α —
—
in 3d

Price Chart

Loading chart...

Executive Summary

Two PTCT insiders — the Chief Technical Operations Officer and the EVP & CLO — sold a combined ~$267K in open-market sales over a 4-day window. The sales are small relative to the company's $6.7B market cap (~0.004%), and the CTO's sale was paired with option exercises, indicating a routine cashless exercise-to-sell pattern. This cluster does not signal material bearish conviction.

Key Financial Metrics

Direction
selling
Total Value
$267.4K
Insiders
2

Key Facts

  • Total open-market sales: ~$267K across 2 insiders
  • Sales represent ~0.004% of PTCT's $6.7B market cap — well below the 0.1% materiality threshold
  • CTO Almstead's sale was a same-day cashless exercise (2,464 options at $46.54 strike, sold at $90.25) — routine tax/vesting-driven disposition
  • EVP & CLO Boulding sold only 519 shares for $45K — de minimis
  • Director Smith's trades on 7/9 (not in cluster window) also show a cashless exercise pattern: exercised 15,834 options at $0/$42.95, sold 15,834 shares at $90 for ~$1.425M — consistent with planned diversification, not a bearish signal

Financial Impact

Total insider sales of ~$267K represent ~0.004% of market cap — immaterial

dilution

Risk Factors

  • Insider sales could accelerate if the stock continues to appreciate, but current levels are not alarming
  • No material risk signaled by this cluster

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PTCT-1784008926663
15 reports for PTCT
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +19.01%Apr 28, 2026
Filters
Rows
Reports for PTCT — sortable, filterable
TypeNow
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$69.82 $65.26▼ −6.53%▼ −6.00%$63.46 (−9.11%)
Jul 16, 2026
11w ago
Press Release
BEARISH ★ 7/10
$78.52 $71.97▲ +8.34%▲ +11.96%$63.46 (+19.18%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$78.52 $71.97▼ −8.34%▼ −11.96%$63.46 (−19.18%)
Jul 13, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$81.33 $74.63▼ −8.24%▼ −11.42%$63.46 (−21.97%)
Jul 8, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$88.57 $69.21▼ −21.86%▼ −25.13%$63.46 (−28.35%)
Jun 26, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$81.57 $76.82▼ −5.82%▼ −5.54%$63.46 (−22.20%)
Jun 16, 2026
15w ago
8-K
NEUTRAL ★ 5/10
$73.27 $78.06▲ +6.54%▲ +6.34%$63.46 (−13.39%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$73.35 $89.55▲ +22.09%▲ +18.46%$63.46 (−13.48%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.02 $78.98▲ +11.21%▲ +10.47%$63.46 (−10.64%)
May 15, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$70.15 $73.27▲ +4.45%▲ +2.87%$63.46 (−9.54%)
Showing 10 of 15

US Market Status

Market Closed — Opens Mon (65h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 14, 2026